Eric Vansonnenberg

Eric Vansonnenberg

Auto-generated profile, based on publicly available information

Eric Vansonnenberg

Department of Radiology, University of Arizona College of Medicine–Phoenix, PO Box 425, Cave Creek, AZ 85327

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2005 in American Journal of Roentgenology
Verified
Journal Article
Closed access
EVEric Vansonnenberg
Eric Vansonnenberg
SSSridhar Shankar
Sridhar Shankar
PMPaul R. Morrison
Paul R. Morrison
RNRashmi T. Nair
Rashmi T. Nair
SSStuart G. Silverman
Stuart G. Silverman
DSDavid J. Sugarbaker
David J. Sugarbaker
OBJECTIVE. The purpose of our study was to report our initial experience with patients who underwent percutaneous imaging-guided radiofrequency ablation of thoracic lesions, and to emphasize technical and multidisciplinary issues and adjunctive procedures specific to thoracic tumor ablation.MATERIALS AND METHODS. Our cohort consisted of 30 patients with a spectrum of primary (n = 18) and secondary (n = 11) lung tumors, mesothelioma (n = 1), and five secondarily eroded, painful ribs who underwent ablation of 36 total lesions (one patient had two ablations). Patients either were nonsurgical candidates because of medical comorbidities or extent of disease, or had exhausted chemotherapy and radiation therapy options, or had refused surgery or undergone unsuccessful surgery. Patients were treated with radiofrequency ablation after agreement among oncologists, thoracic surgeons, and interventional radiologists. An array-style electrode under impedance control was used to treat 29 thoracic tumors and the adjacen...

17 August 2022 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
BNBrandon Ngo
Brandon Ngo
DNDiep Nguyen
Diep Nguyen
EVEric Vansonnenberg
Eric Vansonnenberg
“Just Accepted” papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review ...

1 July 2014 in American Journal of Roentgenology
Verified
Journal Article
Closed access
MMMark D. Mamlouk
Mark D. Mamlouk
EVEric Vansonnenberg
Eric Vansonnenberg
SDSeena Dehkharghani
Seena Dehkharghani
The objective of our study was to help clarify the role of CT-guided pudendal nerve blocks in the problematic and poorly understood entity of pudendal neuralgia (PN). Over a 1-year period, 52 CT-guided pudendal nerve blocks were performed in 31 patients (28 women, three men; age range, 22-80 years) who suffered from chronic pelvic pain with a presumed diagnosis of PN. A combination of anesthetic and steroid was injected into the pudendal (Alcock) canal. Pre- and postprocedural pain scores (0-10) were tallied and assessed by Student t tests. A p value < 0.05 was indicative of a significant difference. All procedures were successful technically, which was defined as contrast material filling the pudendal canal on CT and subsequent infusion of anesthetic and steroid. Pre- and postprocedural pain scores ranged from 2 to 10 (mean score, 6.13) and 0-10 (mean score, 2.14), respectively; the difference was statistically significant for each nerve block session (first session, p < 0.001; second session, p < 0.001; third session, p = 0.049). Of the 31 patients, two had long-term relief with pudendal nerve blocks alone. Fourteen had subsequent surgery based on initial improvement with block(s), and all 14 patients improved with surgical nerve release. Two patients had no diagnostic response and the diagnosis of PN was excluded. The gynecologic service followed the remaining 13 patients clinically. CT-guided pudendal nerve blocks appear to be valuable diagnostically for PN and uncommonly therapeutically. On the basis of these preliminary results, we have developed an algorithm for the role of the procedure for PN.

1 February 2005 in American Journal of Roentgenology
Verified
Journal Article
Closed access
PMPaul R. Morrison
Paul R. Morrison
EVEric Vansonnenberg
Eric Vansonnenberg
SSSridhar Shankar
Sridhar Shankar
JGJohn Godleski
John Godleski
SSStuart G. Silverman
Stuart G. Silverman
FJFerenc A. Jolesz
Ferenc A. Jolesz
OBJECTIVE. Radiofrequency ablation has been used extensively in the liver for the localized thermal coagulation of tumors. It has been applied more recently percutaneously in the lung under CT imaging guidance. In advance of our own clinical application, we performed experimental percutaneous radiofrequency ablation in normal lung tissues in a large animal model using a U.S. Food and Drug Administration–approved device to assess its use.MATERIALS AND METHODS. Radiofrequency ablation of 22 thoracic sites was performed in vivo in three pigs with an array-style electrode. Tissue impedance and ablation duration were measured for each site. The intact lungs were excised for gross inspection and for imaging with CT and MRI. Representative lesions were evaluated histologically.RESULTS. The mean intraprocedural tissue impedance was 93 Ω (range, 52–184 Ω). Six of 22 ablations exhibited a marked increase in impedance after 5 min of treatment. On gross inspection, parenchymal lesions were generally round and targetl...

22 May 2011 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
MMMark Daniel Mamlouk
Mark Daniel Mamlouk
EVEric Vansonnenberg
Eric Vansonnenberg
SSSridhar Shankar
Sridhar Shankar
SSStuart G. Silverman
Stuart G. Silverman
Background: Omental cakes typically are associated with ovarian carcinoma, as this is the most common malignant aetiology. Nonetheless, numerous other neoplasms, as well as infectious and benign processes, can produce omental cakes. Methods: A broader knowledge of the various causes of omental cakes is valuable diagnostically and to direct appropriate clinical management. Results: We present a spectrum of both common and unusual aetiologies that demonstrate the variable computed tomographic appearances of omental cakes. Conclusion: The anatomy and embryology are discussed, as well as the importance of biopsy when the aetiology of omental cakes is uncertain.

23 September 2014 in EPMA Journal
Verified
Journal Article
Open access
PDF file
LBLeonard Berliner
Leonard Berliner
HLHeinz U Lemke
Heinz U Lemke
EVEric Vansonnenberg
Eric Vansonnenberg
HAHani Ashamalla
Hani Ashamalla
MMMalcolm D Mattes
Malcolm D Mattes
PMPaul Morrison
Paul Morrison
Predictive, preventive and personalized medicine (PPPM) may have the potential to eventually improve the nature of health care delivery. However, the tools required for a practical and comprehensive form of PPPM that is capable of handling the vast amounts of medical information that is currently available are currently lacking. This article reviews a rationale and method for combining and integrating diagnostic and therapeutic management with information technology (IT), in a manner that supports patients through their continuum of care. It is imperative that any program devised to explore and develop personalized health care delivery must be firmly rooted in clinically confirmed and accepted principles and technologies. Therefore, a use case, relating to hepatocellular carcinoma (HCC), was developed. The approach to the management of medical information we have taken is based on model theory and seeks to implement a form of model-guided therapy (MGT) that can be used as a decision support system in the treatment of patients with HCC. The IT structures to be utilized in MGT include a therapy imaging and model management system (TIMMS) and a digital patient model (DPM). The system that we propose will utilize patient modeling techniques to generate valid DPMs (which factor in age, physiologic condition, disease and co-morbidities, genetics, biomarkers and responses to previous treatments). We may, then, be able to develop a statistically valid methodology, on an individual basis, to predict certain diseases or conditions, to predict certain treatment outcomes, to prevent certain diseases or complications and to develop treatment regimens that are personalized for that particular patient. An IT system for predictive, preventive and personalized medicine (ITS-PM) for HCC is presented to provide a comprehensive system to provide unified access to general medical and patient-specific information for medical researchers and health care providers from different disciplines including hepatologists, gastroenterologists, medical and surgical oncologists, liver transplant teams, interventional radiologists and radiation oncologists. The article concludes with a review providing an outlook and recommendations for the application of MGT to enhance the medical management of HCC through PPPM.